Tumour Localisation With Magnetic Clip Before Neoadjuvant Chemotherapy.
NCT ID: NCT06463600
Last Updated: 2024-06-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
44 participants
INTERVENTIONAL
2024-02-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Premarking of Axillary Nodes Before Start of Neoadjuvant Chemotherapy Using Magnetic Approach
NCT05625698
Magseed Magnetic Marker in Locating Axillary Lymph Nodes in Patients With Breast Cancer Undergoing Surgery
NCT03038152
Evaluation of Magseed as Localization Device for Biopsy Proven Metastatic Axillary Lymph Nodes
NCT03718455
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
NCT06049446
Sienna+® Injection Time Study 4 Arms
NCT02612870
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tumour localisation with Magseed
Before preoperative chemotherapy a Magseed is inserted in the breast tumour
Magseed
Tumour localizer
Metallic marker + guide wire
Before preoperative chemotherapy an ordinary metallic clip is inserted in the breast tumour. Before surgery a guide wire is inserted to localise the clip.
Metallic clip and guide wire
Tumour localizers
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Magseed
Tumour localizer
Metallic clip and guide wire
Tumour localizers
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Planned for preoperative chemotherapy before breast cancer surgery
3. Planned breast conserving surgery with targeted axillary dissection or sentinel lymph node biopsy using magnetic technique
4. SLN-biopsy with magnetic tracer or targeted axillary dissection using magnetic tracer and Magseed
5. Signed and dated written informed consent before the start of specific protocol procedures
Exclusion Criteria
2. Iron overload disease
3. Known hypersensitivity to iron or dextran compounds
4. Inability to understand given information and give informed consent or undergo study procedures
5. Planned MRI control for tumour response during chemotherapy
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sahlgrenska University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Professor Fredrik Warnberg
professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roger Olofsson Bagge, prof
Role: PRINCIPAL_INVESTIGATOR
Sahlgrenska Academy at Gothenburg University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sahlgrenska Academy at Gothenburg University
Gothenburg, Göteborg, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SUGBG-2023001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.